About Steven Girouard
Steven Girouard, PhD, is a medical device executive. He is an executive officer of SymKardia. SymKardia is developing selective cardiac neuromodulation as a treatment for arrhythmias. He also serves as a board director and consultant for several device startups. These include AtaCor, LumaVision Ltd, Prima Medical, PolyVascular, ONWARD and Attune.
Girouard was president and chief executive officer of Securus Medical. He led the company through FDA approvals and its sale to Boston Scientific. He was also a partner at Oakwood Medical Investors and Omega Funds. He has also held senior management roles at Johnson & Johnson, Guidant and Cleveland Clinic. PolyVascular announced on June 1, 2024 that he had joined its board of directors. PolyVascular is developing a non-surgical pulmonary valve for children. He has a bachelor's degree in biomedical engineering from Boston University. His master's and doctoral degrees in that field are from Case Western Reserve University.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Steven Girouard in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Steven Girouard works with at each company, as listed on that company's latest Form D.
